This study demonstrated that BARX2 indirectly activates PHLDA3 transcription, leading to PI3K/AKT suppression and subsequent inhibition of ESCC cell proliferation, migration, invasion, and angiogenesis. This evidence concerns the gene BARX2 and esophageal squamous cell carcinoma.